Meditolp (Tolperisone Hydrochloride)

Tolperisone Hydrochloride blocks voltage‑gated sodium channels in the spinal cord and brainstem, lowering neuronal excitability. This reduces the reflex pathways that maintain high muscle tone, resulting in decreased muscle rigidity and spasm without causing strong central sedation.

The dosage of Meditolp is determined by the prescribing healthcare professional based on the individual’s condition, age, weight and response to therapy. Patients should follow the prescriber’s instructions and not adjust the dose without medical advice.

Safety data for Tolperisone Hydrochloride in pregnancy and lactation are limited. It should only be used when the potential benefit to the mother outweighs any possible risk to the fetus or infant, and under close medical supervision.

To order Meditolp, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Compared with agents such as baclofen or tizanidine, Tolperisone Hydrochloride has a primarily peripheral action on sodium channels and tends to cause less sedation. However, individual response varies, and the choice of therapy depends on the specific clinical scenario and physician judgment.

Meditolp should be stored at ambient temperature, preferably below 25 °C. Keep the product in its original packaging, protect it from moisture and direct sunlight, and ensure the container is tightly closed to maintain stability.

Meditolp is taken orally, usually with a glass of water. It can be administered with or without food, but patients should follow the prescriber’s guidance regarding timing relative to meals to optimize absorption and minimize gastrointestinal discomfort.

Serious adverse reactions, although rare, include severe hypotension, allergic reactions such as anaphylaxis, significant liver enzyme elevations, blood dyscrasias, cardiac arrhythmias and severe skin conditions like Stevens‑Johnson syndrome. Any of these symptoms require immediate medical attention.

Patients with known hypersensitivity to Tolperisone Hydrochloride or any excipients in the formulation should avoid Meditolp. Caution is also advised for individuals with severe hepatic or renal impairment, uncontrolled hypotension, or those taking interacting medications listed under major interactions.